Stock listing
Nasus Pharma Ltd.
Selected listing: NSRX · AMEX · USD · US
Nasus Pharma Ltd. (NYSE American: NSRX), Health Technology. Latest release Sep 14, 2026: Nasus Pharma Announces FDA Clearance to Initiate Clinical Study…
- Ticker
- NYSE American: NSRX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NYSE American
- Currency
- USD
About Nasus Pharma Ltd.
Nasus Pharma Ltd. is a public company traded under the ticker NSRX in the American market. Nasus Pharma focuses on developing innovative pharmaceutical solutions.
Latest news from Nasus Pharma Ltd.
Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis
September 14, 2026
Nasus Pharma Announces Transition of Chief Financial Officer
August 19, 2026
Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
August 17, 2026
Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
July 28, 2026
Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003)
June 9, 2026